Medications That May Affect Gallbladder Health
Medications and Your Gallbladder
What the research says about common prescriptions and bile health — and why it matters for your digestive system.
If you're taking a prescription medication, you probably reviewed the common side effects with your doctor. But one area that often goes undiscussed is how certain medications may influence gallbladder function and bile flow.
The gallbladder plays a central role in digestion. It stores and releases bile — the fluid your liver produces to emulsify dietary fats so your body can absorb them. When bile flow is disrupted, fat digestion can become less efficient, and over time, changes in bile composition or gallbladder motility may occur.
Research has identified several classes of prescription medications that may affect the gallbladder. This page provides an overview of what the published literature says, with links to deeper dives on each category.
Important: This content is educational only and is not medical advice. Gallavance is a dietary supplement, not a medication. It does not treat, cure, or prevent any disease or medication side effect. Always consult your healthcare provider before adding any supplement to your routine.
The Two Pathways: How Medications Affect the Gallbladder
Most medications that influence gallbladder health do so through one or both of these mechanisms:
1. Reduced gallbladder motility (bile stasis)
When the gallbladder doesn't contract and empty properly, bile sits stagnant. Over time, stagnant bile can thicken into sludge, which may form stones. Medications that suppress gallbladder contractions — such as GLP-1 receptor agonists and somatostatin analogues — operate primarily through this pathway.
2. Altered bile composition (lithogenic shift)
Bile is a delicate balance of cholesterol, bile acids, phospholipids, and bilirubin. When that balance shifts — particularly toward excess cholesterol relative to bile acids — bile becomes "lithogenic" (stone-forming). Medications like estrogen-containing therapies and fibrates can shift this balance by increasing cholesterol secretion into bile or reducing bile acid production.
Many medications affect both pathways simultaneously, compounding the impact.
Medication Classes That May Affect Gallbladder Function
GLP-1 Receptor Agonists
Examples: Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), Trulicity® (dulaglutide)
GLP-1 medications slow gastric emptying and reduce gallbladder contractions. Research has documented increased rates of gallbladder disease (cholelithiasis, cholecystitis) in GLP-1 users, with risk increasing at higher doses and longer durations.
Read our full GLP-1 and gallbladder guide →
Hormone Replacement Therapy (HRT) & Oral Contraceptives
Examples: Premarin®, Prempro®, Estrace®, combination birth control pills
Estrogen increases cholesterol secretion into bile, while progesterone reduces gallbladder motility. Together, these effects make bile more prone to stone formation. Large cohort studies have found significantly higher rates of gallstones and cholecystectomy in women using estrogen-containing therapies.
Read: HRT, Oral Contraceptives, and Gallbladder Health →
Proton Pump Inhibitors (PPIs) & H2 Blockers
Examples: Prilosec® (omeprazole), Nexium® (esomeprazole), Protonix® (pantoprazole), Pepcid® (famotidine)
Long-term use of gastric acid suppressants has been associated with increased gallstone risk in recent prospective studies. The mechanism is still being researched but may involve changes to the gut-bile axis and intestinal microbiome that affect bile acid recycling.
Read: PPIs, H2 Blockers, and Gallbladder Health →
Thiazide Diuretics
Examples: Hydrochlorothiazide (HCTZ), chlorthalidone
Often called the "forgotten side effect" of thiazides, a large prospective study of over 81,000 women found that current thiazide users had a 39% higher relative risk of cholecystectomy compared to never-users. The mechanism is not fully understood but may involve altered cholesterol metabolism.
Read: Thiazide Diuretics and Gallbladder Risk →
Fibrates (Cholesterol-Lowering Medications)
Examples: Tricor® (fenofibrate), Lopid® (gemfibrozil), Atromid-S® (clofibrate)
Fibrates suppress bile acid synthesis by downregulating the enzyme CYP7A1, which is critical for converting cholesterol into bile acids. Less bile acid production means bile becomes more lithogenic. Clofibrate carries the highest documented risk — approximately 8-fold increased new gallstone formation in the first year.
Read: Fibrates and Gallstone Risk →
Tamoxifen
Example: Nolvadex® (tamoxifen)
Used in breast cancer treatment, tamoxifen has a striking association with gallstone formation. One study found a 30.4% incidence of gallstones in tamoxifen users versus 0.05% in non-users, with risk increasing after 5 years of treatment. The mechanism involves changes in bile acid conjugation.
Read: Tamoxifen and Gallbladder Health →
Additional Medications With Documented Gallbladder Effects
| Medication Class | Examples | Primary Effect on Gallbladder |
| Somatostatin analogues | Octreotide (Sandostatin®) | Severe gallbladder stasis; up to 50% gallstone incidence within 1 year |
| Ceftriaxone (antibiotic) | Rocephin® | Calcium-ceftriaxone precipitation in bile; 25–45% pseudolithiasis (usually reversible) |
| Immunosuppressants | Cyclosporine, tacrolimus | Altered bile composition; increased cholelithiasis post-transplant |
These medications are typically used in more specialized clinical settings. If you're taking any of these, discuss gallbladder monitoring with your specialist.
Quick-Reference: Medications and Gallbladder Risk
| Medication Class | Risk Level | Primary Mechanism |
| Octreotide (Sandostatin) | Very High (~50%) | Gallbladder stasis + altered bile composition |
| Ceftriaxone | High (25–45%) | Calcium-ceftriaxone precipitation in bile |
| Tamoxifen | High (~30%) | Altered bile acid conjugation |
| Fibrates (esp. clofibrate) | High (8x in year 1) | Reduced bile acid synthesis → lithogenic bile |
| Estrogen / HRT / OCP | Moderate–High | Increased cholesterol in bile; reduced gallbladder motility |
| Thiazide diuretics | Moderate (~39% increased risk) | Mechanism under investigation; altered cholesterol metabolism |
| PPIs / H2 blockers | Moderate | Altered gut-bile axis; microbiome changes |
| Cyclosporine | Moderate | Altered bile composition and reduced bile flow |
How Bile Support May Fit In
If you're taking a medication that may affect your gallbladder, you're not alone — and there are steps you can discuss with your healthcare provider.
Gallavance is formulated to support bile availability during digestion. It provides bile acids and phospholipids in delayed-release capsules designed to open in the intestine, where fat emulsification occurs.
For individuals whose gallbladder function may be influenced by medication, supporting bile availability is an area worth exploring with a healthcare professional.
- Gallavance Original — bile-anchored formula
- Gallavance Plant-Based — 100% plant-derived
Gallavance is a dietary supplement, not a medication. It does not treat, cure, or prevent any disease or medication side effect. All ingredients are fully disclosed — no proprietary blends. Consult your healthcare provider before adding any supplement to your routine.
Important Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. All content on this page is provided for educational purposes only and is not intended as medical advice. The research citations above are provided for informational purposes and do not constitute claims about Gallavance's effects on any medication or condition. Always consult your healthcare provider before starting any supplement regimen, especially if you are taking prescription medications.
Research References
1. U.S. Pharmacist. "Gallstones: Aging and Medications Increase Risk." Link
2. Mendez-Sanchez N, et al. "New insights into the molecular mechanisms underlying effects of estrogen on cholesterol cholelithiasis." Clin Gastroenterol Hepatol. 2009. PubMed
3. Simon JA, et al. "Menopausal hormone therapy increases the risk of gallstones." PMC. 2023. Link
4. Thijs C, et al. "Gallbladder Disease in Women Receiving Estrogen Replacement Therapy." AAFP. 2000. Link
5. Ciarleglio MM, et al. "Thiazide Diuretics and the Risk of Gallbladder Disease Requiring Surgery in Women." JAMA Intern Med. 1994. Link
6. Rasch S, et al. "Regular Use of Gastric Acid Suppressants May Increase the Risk of Gallstones." Medscape. 2022. Link
7. Schoenfield LJ, et al. "Effects of fibric acid derivatives on biliary lipid composition." J Clin Invest. 1987. Link
8. Völzke H, et al. "Investigating the Effects of Tamoxifen on Bile Components and Gallstone Formation." UMJ. Link
9. Pereira SP, et al. "Drug-induced gallbladder disease. Incidence, aetiology and management." Drug Saf. 1994. PubMed
10. Catnach SM, et al. "Gallstones during octreotide therapy." Gut. 1992. PubMed
11. Bick RJ, et al. "Proton pump inhibitors and the risk of gallbladder cancer." Gut. 2020. Link
Tools to Track Your First 14 Days
Use these trackers to log your daily comfort, meals, and any changes you notice while you settle into Gallavance. They're optional, but they make it easier to see patterns over the first two weeks.